Skip to main content

Table 4 Surgical and pathological characteristics according to the inflection points in the three learning curves

From: The taTME learning curve for mid-low rectal cancer: a single-center experience in China

Variable

Operation-time group

P

Postoperative-complication group

Anastomotic-leakage group

P

Consecutive. of patients

1–42

43–104

 

1–43

44–75

76–104

1–68

69–98

 

Total operation time, min, median (IQR)

295.0 (251.0–330.0)

220.0 (180.0–240.0)

< 0.001

290.0 (250.–330.0)

228.5 (211.5–255.5)

199.0 (180.0–238.0)

256.0 (220.0–308.5)

199.5 (180.0–239.5)

< 0.001

Intraoperative blood loss, mL, median (IQR)

100.0 (57.5–200.0)

100.0 (50.0–100.0)

0.173

100.0 (65.0–200.0)

100.0 (50.0–100.0)

100.0 (50.0–100.0)

100.0 (50.0–100.0)

100.0 (50.0–100.0)

0.491

Anastomotic technique, n (%)

  

< 0.001

     

0.092

    Manual

15 (35.7%)

11 (17.7%)

 

16 (37.2%)

6 (18.8%)

4 (13.8%)

22 (32.4%)

4 (13.3%)

 

    Stapled

18 (42.9%)

50 (80.6%)

 

18 (41.9%)

26 (81.2%)*

24 (82.8%)#

43 (63.2%)

25 (83.3%)

 

    Stapled and reinforced manually

3 (7.1%)

1 (1.6%)

 

3 (7.0%)

0 (0.0%)

1 (3.4%)

3 (4.4%)

1 (3.3%)

 

    None

6 (14.3%)

0 (0.0%)

 

6 (14.0%)

0 (0.0%)

0 (0.0%)

NA

NA

 

Stoma creation, n (%)

  

0.003

     

0.010

    None

1 (2.4%)

5 (8.1%)

 

1 (2.3%)

0 (0.0%)

5 (17.2%)&

29 (42.6%)

0 (0.0%)

 

    Diverting loop ileostomy

35 (83.3%)

57 (91.9%)

 

36 (83.7%)

32 (100.0%)*

24 (82.8%)&

39 (57.4%)

30 (100.0%)

 

    Permanent colostomy

6 (14.3%)

0 (0.0%)

 

6 (14.0%)

0 (0.0%)

0 (0.0%)

NA

NA

 

Transanal tube use, n (%)

18 (42.9%)

54 (87.1%)

< 0.001

19 (44.2%)

24 (75.0%)*

29 (100.0%)#&

39 (57.4%)

30 (100.0%)

< 0.001

Conversion to open, n (%)

2 (4.8%)

0 (0.0%)

0.161

2 (4.7%)

0 (0.0%)

0 (0.0%)

0

0

NA

Reoperation, n (%)

1 (2.4%)

2 (3.2%)

0.801

1 (2.3%)

2 (6.2%)

0 (0.0%)

2 (2.9%)

0 (0.0%)

1.0

  1. *P < 0.05, comparison between phases 2 and 1. #P < 0.05, comparison between phases 3 and 1. &P < 0.05, comparison between phases 3 and 2